Old Mission Capital’s Cano Health, Inc. CANO Stock Holding History

Old Mission Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-159	Closed	-$101K	–	1905
2022 Q1	$101K	Buy	+159	New	+$100K	﹤0.01%	1189

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Old Mission Capital's CANO Position: Q2 2022 in Review

Old Mission Capital sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 159 shares — an estimated $101K sold.

Old Mission Capital first reported a position in CANO in Q1 2022 and held it in 1 quarter. The position peaked at $101K in Q1 2022. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

Old Mission Capital reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
Old Mission Capital sold 159 Cano Health, Inc. shares in Q2 2022, an estimated $101K.
Old Mission Capital first reported a position in Cano Health, Inc. in Q1 2022 and held it in 1 quarter.
Old Mission Capital's Cano Health, Inc. position peaked at $101K in Q1 2022.
144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on Old Mission Capital's 13F filing for Q2 2022, filed 5 Aug 2022.